Hu et al. [73] showed that the overexpression of human lipocalin-2 in hepatocytes reduces atherosclerosis development via scavenger receptor group B type 1 (SR-B1) in western-diet-fed LDL receptor (LDLR) −/− mice. The gene discussed is LDLR; the disease is atherosclerosis.